CTMX vs AMZN · rev $11.7M vs P/E 31, rev $716.92B
CytomX Therapeutics Inc (CTMX) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
CTMX currently screens at market cap $653.1M. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the CTMX and AMZN stock pages for the full models.
Not investment advice.